Continuity Biosciences, LLC
1 clinical trials · Sponsor
◉ Watch Continuity Biosciences, LLC
| Record | Firm | Date |
|---|---|---|
| A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer (NCT07481383) | Continuity Biosciences, LLC | 2026-03-11 |
Track Continuity Biosciences, LLC automatically
Every clearance here is in the API, with alerts when new ones post.